The typical approach to controlling meeting costs in pharmaceutical companies is to do so externally — that is, to manage expenses through relationships with suppliers and by negotiating. But Bristol-Myers Squibb Co. has taken an unusual and forward-thinking approach, implementing a system called consumption and specification management (CSM).
Register to view the full article
Register for MeetingsNet.com and gain access to premium content including the CMI 25 Listing, our monthly digital edition, the MeetingsNet app, live and on-demand webinars, and much more.
0 comments
Hide comments